Current Drug Metabolism
Volume 20, 14 Issues, 2019
ISSN: 1875-5453 (Online)
ISSN: 1389-2002 (Print)
This journal supports open access
ISSN: 1875-5453 (Online)
ISSN: 1389-2002 (Print)
This journal supports open access
Ranking and Category
-
200th of 298 in
Biochemistry & Molecular Biology
-
158th of 267 in
Pharmacology & Pharmacy
Contents
Current Drug Metabolism, Volume 18 - Number 2
Biography
Editorial
Editorial: Frontier View on Drug Discoveries for Different Diseases - Part II
, 18(2): 88 - 89Mohammad Amjad Kamal
DOI: 10.2174/138920021802170321222741
Review Article
Phage Display Technique: A Novel Medicinal Approach to Overcome An tibiotic Resistance by Using Peptide-Based Inhibitors Against β-Lactamases
, 18(2): 90 - 95Ghazala Muteeb, Md. Tabish Rehman, Saeedut Zafar Ali, Abdurrahman M. Al-Shahrani, Mohammad Amjad Kamal and Ghulam Md. Ashraf
DOI: 10.2174/1389200217666160727100434
Phage Display Technique: A Novel Medicinal Approach to Overcome An tibiotic Resistance by Using Peptide-Based Inhibitors Against β-Lactamases
Review Article
A Current Perspective on the Inhibition of Cholinesterase by Natural and Synthetic Inhibitors
, 18(2): 96 - 111Anzer A. Shah, Tanveer A. Dar, Parvaiz A. Dar, Showkat A. Ganie and Mohammad A. Kamal
DOI: 10.2174/1389200218666161123122734
A Current Perspective on the Inhibition of Cholinesterase by Natural and Synthetic Inhibitors
Review Article
Ginkgo biloba as an Alternative Medicine in the Treatment of Anxiety in Dementia and other Psychiatric Disorders
, 18(2): 112 - 119Sandeep Kumar Singh, George E. Barreto, Gjumrakch Aliev and Valentina Echeverria
DOI: 10.2174/1389200217666161201112206
Ginkgo biloba as an Alternative Medicine in the Treatment of Anxiety in Dementia and other Psychiatric Disorders
Review Article
A Review on Nano-Antimicrobials: Metal Nanoparticles, Methods and Mechanisms
, 18(2): 120 - 128Edris Hoseinzadeh, Pouran Makhdoumi, Parisa Taha, Hooshyar Hossini, John Stelling, Mohammad Amjad Kamal and Ghulam Md. Ashraf
DOI: 10.2174/1389200217666161201111146
A Review on Nano-Antimicrobials: Metal Nanoparticles, Methods and Mechanisms
Review Article
Nanoparticles as a Carrier System for Drug Delivery Across Blood Brain Barrier
, 18(2): 129 - 137Alika Sarkar, Ismat Fatima, Qazi Mohammad Sajid Jamal, Usman Sayeed, Mohammad Kalim A. Khan, Salman Akhtar, Mohammad Amjad Kamal, Alvina Farooqui and Mohammad Haris Siddiqui
DOI: 10.2174/1389200218666170113125132
Nanoparticles as a Carrier System for Drug Delivery Across Blood Brain Barrier
Review Article
Potential of Plant Alkaloids as Antipyretic Drugs of Future
, 18(2): 138 - 144Imad Ahmad, Haroon Khan, Anwar-ul-Hassan Gilani and Mohammad Amjad Kamal
DOI: 10.2174/1389200218666170116102625
Potential of Plant Alkaloids as Antipyretic Drugs of Future
Review Article
Sonication-Assisted Nanoprecipitation in Drug Delivery
, 18(2): 145 - 156Anh Thi Ngoc Vo, Thinh Duc Luu, Minh Ngoc Uyen Nguyen, Toi Van Vo, Wei Duan, Phuong Ha-Lien Tran and Thao Truong-Dinh Tran
DOI: 10.2174/1389200218666170116103555
Sonication-Assisted Nanoprecipitation in Drug Delivery
Review Article
Challenges Related to Glycemic Control in Type 2 Diabetes Mellitus Patients
, 18(2): 157 - 162Masoumeh Kheirandish, Hamidreza Mahboobi, Maryam Yazdanparast and Mohammad Amjad Kamal
DOI: 10.2174/1389200218666170116105023
Challenges Related to Glycemic Control in Type 2 Diabetes Mellitus Patients
Review Article
Glycosides as Possible Lead Antimalarial in New Drug Discovery: Future Perspectives
, 18(2): 163 - 171Marya, Haroon Khan, Gohar Mushtaq, Mohammad Amjad Kamal and Izhar Ahmad
DOI: 10.2174/1389200218666170116105527
Glycosides as Possible Lead Antimalarial in New Drug Discovery: Future Perspectives
  |
Editor-in-Chief
Michael Sinz
Bristol Myers Squibb
Princeton, NJ
USA
Biography
View Full Editorial Board
Bristol Myers Squibb
Princeton, NJ
USA
Biography
Biography of Michael Sinz
Michael W. Sinz, Ph.D. is Director of Metabolism and Pharmacokinetics at Bristol Myers Squibb where he manages ADmezME lead optimization in drug discovery. Dr. Sinz previously held the position of Section Director-Pharmacokinetics and Drug Metabolism for Parke-Davis/Pfizer. He received B.S. degrees in Chemistry (ACS) and Biology from the University of Wisconsin-Eau Claire and a Ph.D. in Pharmacognosy/Medicinal Chemistry from the University of Minnesota (2001). He is editor in chief of Current Drug Metabolism and associate editor of Drug Metabolism Letters. Dr. Sinz’s resume includes an extensive number of peer reviewed publications, book chapters, and external presentations both locally and internationally.
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Drug Metabolism was launched in 2000. Dr. Michael Sinz serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net